Osteoporosis: Romosozumab to rebuild the foundations of bone strength
Nat Rev Rheumatol
.
2018 Mar;14(3):128.
doi: 10.1038/nrrheum.2018.5.
Epub 2018 Jan 25.
Author
Serge L Ferrari
1
Affiliation
1
Service and Laboratory of Bone Diseases, Geneva University Hospital, 1205 Geneva, Switzerland.
PMID:
29367691
DOI:
10.1038/nrrheum.2018.5
No abstract available
Publication types
Comment
MeSH terms
Alendronate
Antibodies, Monoclonal
Female
Fractures, Bone*
Humans
Osteoporosis*
Substances
Antibodies, Monoclonal
romosozumab
Alendronate